Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation

Journal of Virology

Volumn 85, Issue 15, 2011, Pages 7555-7562

  Sohn, Sook Young ^a   Hearing, Patrick ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COGNATE PROTEIN TYROSINE PHOSPHATASE TC45; PROTEIN TYROSINE PHOSPHATASE; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADENOVIRUS INFECTION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION;

ADENOVIRIDAE; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; INTERFERON-ALPHA; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; TYROSINE; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 79960420849     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00513-11     Document Type: Article

References (50)

1. Ackrill, A. M., et al. 1991. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19:4387-4393.
2. Anderson, K. P., and E. H. Fennie. 1987. Adenovirus early region 1A modulation of interferon antiviral activity. J. Virol. 61:787-795.
3. Araujo, F. D., T. H. Stracker, C. T. Carson, D. V. Lee, and M. D. Weitzman. 2005. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 79:11382-11391.
4. Carvalho, T., et al. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
5. Doucas, V., et al. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207.
6. Evans, J. D., and P. Hearing. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79:6207-6215.
7. Flowers, L. O., et al. 2004. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J. Immunol. 172:7510-7518.
8. Gaynor, R. B., A. Tsukamoto, C. Montell, and A. J. Berk. 1982. Enhanced expression of adenovirus transforming proteins. J. Virol. 44:276-285.
9. Gutch, M. J., and N. C. Reich. 1991. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. U. S. A. 88:7913-7917.
10. Hayes, B. W., G. C. Telling, M. M. Myat, J. F. Williams, and S. J. Flint. 1990. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64:2732-2742.
11. Horwitz, M., C. Brayton, and S. Baum. 1973. Synthesis of type 2 adenovirus DNA in the presence of cycloheximide. J. Virol. 11:544-551.
12. Jones, N., and T. Shenk. 1978. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181-188.
13. Kalvakolanu, D. V., S. K. Bandyopadhyay, M. L. Harter, and G. C. Sen. 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. U. S. A. 88:7459-7463.
14. Kim, T., and T. Maniatis. 1996. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273:1717-1719.
15. Kitajewski, J., et al. 1986. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 [alpha] kinase. Cell 45:195-200.
16. Krämer, O., et al. 2009. A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev. 23:223-235.
17. Lee, C., H. Bluyssen, and D. Levy. 1997. Regulation of interferon-responsiveness by the duration of Janus kinase activity. J. Biol. Chem. 272:21872-21877.
18. Leonard, G. T., and G. C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25-33.
19. Liu, B., et al. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. U. S. A. 95:10626-10631.
20. Look, D., et al. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871-880.
21. Marshall, L. J., et al. 2008. RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis. J. Virol. 82:6395-6408.
22. McBride, K., C. McDonald, and N. Reich. 2000. Nuclear export signal located within the DNA-binding domain of the STAT1 transcription factor. EMBO J. 19:6196-6206.
23. Mertens, C., et al. 2006. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev. 20:3372-3381.
24. Mowen, K., et al. 2001. Arginine methylation of STAT1 modulates IFN [alpha]/[beta]-induced transcription. Cell 104:731-741.
25. Nakao, K., et al. 1999. p48 (ISGF-3) is involved in interferon-induced suppression of hepatitis B virus enhancer-1 activity. J. Biol. Chem. 274:28075-28078.
26. Nociari, M., O. Ocheretina, M. Murphy, and E. Falck-Pedersen. 2009. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J. Virol. 83:4081-4091.
27. Platanias, L. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5:375-386.
28. Pombo, A., J. Ferreira, E. Bridge, and M. Carmo-Fonseca. 1994. Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J. 13:5075-5085.
29. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
30. Rang, A., T. Heise, and H. Will. 2001. Lack of a role of the interferonstimulated response element-like region in interferon-induced suppression of hepatitis B virus in vitro. J. Biol. Chem. 276:3531-3535.
31. Reich, N., R. Pine, D. Levy, and J. E. Darnell, Jr. 1988. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J. Virol. 62:114-119.
32. Rogers, R. S., C. M. Horvath, and M. J. Matunis. 2003. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J. Biol. Chem. 278:30091-30097.
33. Rosa-Calatrava, M., L. Grave, F. Puvion-Dutilleul, B. Chatton, and C. Kedinger. 2001. Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization. J. Virol. 75:7131-7141.
34. Rosa-Calatrava, M., F. Puvion-Dutilleul, P. Lutz, and D. Dreyer. 2003. Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation. EMBO Rep. 4:969-975.
35. Routes, J. M., H. Li, S. T. Bayley, S. Ryan, and D. J. Klemm. 1996. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding. J. Immunol. 156:1055-1061.
36. Sgarbanti, M., et al. 2002. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J. Exp. Med. 195:1359-1370.
37. Shi, L., M. Ramaswamy, L. Manzel, and D. Look. 2007. Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus. Am. J. Respir. Cell Mol. Biol. 37:720-728.
38. Shuai, K., C. Schindler, V. Prezioso, and J. Darnell, Jr. 1992. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-1812.
39. Souquere Besse, et al. 2002. Adenovirus infection targets the cellular protein kinase CK2 and RNA activated protein kinase (PKR) into viral inclusions of the cell nucleus. Microsc. Res. Tech. 56:465-478.
40. Stracker, T. H., C. T. Carson, and M. D. Weitzman. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
41. Ten Hoeve, et al. 2002. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22:5662-5668.
42. Tsunoda, T., and T. Takagi. 1999. Estimating transcription factor bindability on DNA. Bioinformatics 15:622-630.
43. Ullman, A. J., N. C. Reich, and P. Hearing. 2007. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J. Virol. 81:4744-4752.
44. Ungureanu, D., S. Vanhatupa, J. Gronholm, J. J. Palvimo, and O. Silvennoinen. 2005. SUMO-1 conjugation selectively modulates STAT1-mediated gene responses. Blood 106:224-226.
45. Ungureanu, D., et al. 2003. PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102:3311-3313.
46. Vuong, B. Q., et al. 2004. SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome. Mol. Cell. Biol. 24:9092-9101.
47. Wen, Z., Z. Zhong, and J. E. Darnell. 1995. Maximal activation of transcription by Statl and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
48. Wu, T., et al. 2002. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J. Biol. Chem. 277:47572-47580.
49. Xie, L., Y. Zhang, and Z. Zhang. 2002. Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant. Biochemistry 41:4032-4039.
50. Yamamoto, T., et al. 2002. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun. 297:811-817.